Aberdeen Group
BDSX icon

Aberdeen Group’s Biodesix BDSX Stock Holding History

Aberdeen Group’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.65M Buy
458,438
+196,013
+75% +$2.43M 0.01% 659
2025
Q4 		$1.78M Buy
+262,425
New +$1.93M ﹤0.01% 788

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

Aberdeen Group's BDSX Position: Q1 2026 in Review

Aberdeen Group increased its Biodesix (BDSX) stake by 75% in Q1 2026, buying an estimated $2.43M and bringing the position to 458,438 shares worth $6.65M. The position accounts for 0.01% of the portfolio, ranked #659.

Aberdeen Group first reported a position in BDSX in Q4 2025 and has held it in 2 quarters since. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • Aberdeen Group held 458,438 shares of Biodesix worth $6.65M as of Q1 2026.
  • Aberdeen Group bought 196,013 Biodesix shares in Q1 2026, an estimated $2.43M.
  • Biodesix made up 0.01% of Aberdeen Group's portfolio in Q1 2026, its #659 holding.
  • Aberdeen Group first reported a position in Biodesix in Q4 2025 and has held it in 2 quarters since.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Aberdeen Group's 13F filing for Q1 2026, filed 29 Apr 2026.